← Eichor
Study identifier: NCT06383273 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)

Condition: Cataract  ·  Sponsor: Melt Pharmaceuticals

PhasePhase 3
Planned participants528
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

The goal of this clinical trial is to learn if MELT-300 works on procedural sedation in adult participants undergoing cataract extraction with lens replacement (CELR). It will also learn about the safety of MELT-300. Researchers will compare MELT-300 to a placebo (a look-alike substance that contains no drug) to see if MELT-300 works on procedural sedation in adult participants undergoing CELR. Researchers will also include a comparator SL midazolam to confirm the benefit of inclusion of ketamine in the combined drug product. The main questions it aims to answer are: 1. Does MELT-300 is effective in comparison to placebo on procedural sedation for cataract surgery? 2. To determine the effectiveness of MELT-300 compared with midazolam on procedural sedation (to determine the contribution of ketamine component and inform the risk of ketamine in MELT-300) 3. To determine the time to achieve preoperative target sedation level with MELT-300 4. What medical problems do participants have when taking MELT-300 vs placebo Eligible participants will admitted to the study unit on Day 1. Participants will be randomized prior to surgery 4:1:1 to 1. MELT-300 (i.e. 1 MELT-300 sublingual tablet which contains 3 mg midazolam and 50 mg of ketamine) 2. Midazolam (i.e. 1 matching midazolam sublingual tablet which contains 3 mg midazolam) 3. Placebo (i.e. 1 matching placebo sublingual tablet) Participants will receive study medication 30 (± 5) minutes, without food or water, before planned su…

This description comes directly from the study's public registry record.

Talk to the study team

Giovanni DeCastro  ·  6157670074  ·  gdecastro@meltpharma.com

Larry Dillaha  ·  6157670074  ·  ldillaha@harrowinc.com

Always discuss trial participation with your own doctor first.

Locations (12)

Ridge Eye Care, Inc.Chico, California, United StatesRecruiting
Icon Eye CareGrand Junction, Colorado, United StatesRecruiting
Levenson Eye AssociatesJacksonville, Florida, United StatesRecruiting
Maryland Vision InstituteHagerstown, Maryland, United StatesRecruiting
Vance Thompson Vision- AlexandriaAlexandria, Minnesota, United StatesRecruiting
Tekwani Vision CenterBay Saint Louis, Mississippi, United StatesRecruiting
Bergstrom Eye ResearchFargo, North Dakota, United StatesRecruiting
Vance Thompson Vision, NDWest Fargo, North Dakota, United StatesRecruiting
Northeastern Eye InstituteScranton, Pennsylvania, United StatesRecruiting
Conway OphthalmologyConway, South Carolina, United StatesRecruiting
Vance Thompson VisionSioux Falls, South Dakota, United StatesRecruiting
Utah Eye Centers- Pleasant GrovePleasant Grove, Utah, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06383273